APPLICATION
NDA019775
TYPE
NDA
ORIGINAL APPROVAL
1992-01-29
LATEST ACTION
1995-06-19
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
MINIPRESS XLDiscontinued
PRAZOSIN HYDROCHLORIDE 5MG · TABLET, EXTENDED RELEASE · ORAL
MINIPRESS XLDiscontinued
PRAZOSIN HYDROCHLORIDE 2.5MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
1995-06-19Manufacturing (CMC) · Supplement 2 · standardAP
1994-05-10Manufacturing (CMC) · Supplement 1 · standardAP
1992-01-29Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.